Compare ARK Genomic Revolution ETF (ARKG) vs Western Alliance Bancorporation (WAL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Western Alliance Bancorporation — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Western Alliance Bancorporation trades at $80.69 (market cap $8.81B). The key difference: Western Alliance Bancorporation pays a 2.08% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Western Alliance Bancorporation nearer its low. Which is the better fit depends on your goals.
| ARKG | WAL | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $96.08 |
52-Week Low | $23.09 | $66.70 |
Market Cap | — | $8.81B |
Dividend Yield | — | 2.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Western Alliance Bancorporation (WAL) trades at $80.69, up 0.85% on the day, with a bearish technical signal from moving averages but neutral oscillators. The stock shows strong fundamentals with a P/E of 9.39 and net income margin of 25.63%, supported by three consecutive quarterly earnings beats. Recent news highlights business expansion, including a $33 million Las Vegas redevelopment loan and recognition as Arizona's top bank by Forbes in 2026.
The outlook is positive given analyst consensus with a $90.67 price target and 79% buy ratings, though risks include negative operating cash flow and high interest expenses. Earnings growth and strategic hires in commercial real estate and entertainment financing present opportunities, but investor caution is warranted near technical resistance at $82.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Western Alliance Bancorporation
Western Alliance Bancorporation is a top-performing bank holding company that operates a dual business model: high-touch regional banking and specialized national business lines. It serves niche industries—including technology, life sciences, and homeowners associations—providing sophisticated commercial lending and treasury solutions that bridge the gap between regional service and national scale.
Read more on WAL →
